Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.56542 | 59 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.38527 | 55 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.36011 | 55 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.23737 | 53 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.29718 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.69928 | 60 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.51959 | 56 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.36488 | 55 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.32326 | 54 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.34405 | 55 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.38646 | 56 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.29289 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.50066 | 58 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.38628 | 55 |